Safety and Clinical Activity of FX-909, a First-in-Class Oral Small Molecule Inhibitor of Peroxisome Proliferator-Activated Receptor Gamma (PPARG), the Master Regulator of Luminal Lineage, in Patients with Advanced Urothelial Carcinoma